Our adjuvant technology is used in a growing number of research projects targeting human applications. Below is a selection of some interesting vaccine projects that are currently in pipeline.

Preclinical

• Influenza vaccine
  Isconova Low-tox adjuvant

Isconova conducts extensive research in collaboration with partner companies, in order to maintain a strong flow of new projects. Below is a selection of veterinary projects in pipeline as well as previous projects that today are on the market.

On market

• Equilis® Prequenza (equine influenza) and
  Equilis® Prequenza TE (equine influenza with tetanus)
  Matrix vaccines
  Provided by Intervet International BV
  On market since November 2006

• Bovine Viral Diarrhea Virus vaccine
  Matrix vaccine
  Provided by a Global Animal Health Corporation
  On market since 2003

• Equine LHRH vaccine
  Matrix vaccine
  Provided by a Global Animal Health Corporation
  On market since 2002

• Equip® F (equine influenza) and
  Equip®FT (equine influenza with tetanus)
  ISCOM-vaccines
  Provided by Schering-Plough
  On market since 1997

Discovery

• Bovine SA Mastitis
  vaccine candidate